title: Current innovations in sentinel lymph node mapping for the staging and treatment of resectable lung cancer.
abstract: Despite surgical resectability, early-stage lung cancer remains a challenge to cure. Survival outcomes are hindered by variable performance of adequate lymphadenectomy and the limitations of current pathologic nodal staging. Sentinel lymph node (SLN) mapping, a mainstay in the management of breast cancer and melanoma, permits targeted nodal sampling for efficient and accurate staging that can influence both intraoperative and adjuvant treatment decisions. Unfortunately, standard SLN identification techniques with blue dye and radiocolloid tracers have not been shown to be reproducible in lung cancer. In more recent years, intraoperative near-infrared image-guided lung SLN mapping has emerged as promising technology for the identification of the tumor-associated lymph nodes most likely to contain metastatic disease. Additionally, the clinical relevance of SLN mapping for lung cancer remains pressing, as the ability to identify micrometastatic disease in SLNs could facilitate trials to assess chemotherapeutic response and the clinical effect of occult nodal disease. This review outlines the status of lung cancer lymphatic mapping and techniques in development that may help close the gap between translational research in this field and routine clinical practice.
authors.affiliation: Brigham & Women's Hospital, Boston, Massachusetts.
authors.forename: Krista J
authors.initials: KJ
authors.lastname: Hachey
authors.affiliation: Brigham & Women's Hospital, Boston, Massachusetts. Electronic address: ycolson@partners.org.
authors.forename: Yolonda L
authors.initials: YL
authors.lastname: Colson
mesh_terms: D000818:Animals; D003287:Contrast Media; D005456:Fluorescent Dyes; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery*; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000473:pathology*; D008207:Lymphatic Metastasis; D008220:Lymphography / Q000379:methods; D061206:Neoplasm Micrometastasis; D009367:Neoplasm Staging / Q000379:methods*; D011237:Predictive Value of Tests; D019265:Spectroscopy, Near-Infrared / Q000379:methods; D014057:Tomography, X-Ray Computed
chemical_list: D003287:Contrast Media; D005456:Fluorescent Dyes
keywords: lung cancer; near infrared lymphatic mapping; sentinel lymph node; staging